Document ID: chunk:federal_register_of_legislation:F2024L01524:schedule:1:p2
Version: federal_register_of_legislation:F2024L01524
Segment Type: schedule
Provision Reference: sch 1 (pt 2/38)
Character Range: 4837–7743

(controlled release)  Oral  Tegretol CR 200  NV  MP NP             200  2     200
Carbamazepine  Tablet 200 mg (controlled release)  Oral  Tegretol CR 200  NV  MP NP     P14238  400  2     100
Carbamazepine  Tablet 200 mg (controlled release)  Oral  Tegretol CR 200  NV  MP NP     P14238  400  2     200
Carbamazepine  Tablet 400 mg (controlled release)  Oral  Tegretol CR 400  NV  PDP               200  0     100
Carbamazepine  Tablet 400 mg (controlled release)  Oral  Tegretol CR 400  NV  PDP               200  0     200
Carbamazepine  Tablet 400 mg (controlled release)  Oral  Tegretol CR 400  NV  MP NP             200  2     100
Carbamazepine  Tablet 400 mg (controlled release)  Oral  Tegretol CR 400  NV  MP NP             200  2     200
Carbamazepine  Tablet 400 mg (controlled release)  Oral  Tegretol CR 400  NV  MP NP     P14238  400  2     100
Carbamazepine  Tablet 400 mg (controlled release)  Oral  Tegretol CR 400  NV  MP NP     P14238  400  2     200

[10] Schedule 1, Part 1, omit entries for Carmellose in the form Eye drops containing carmellose sodium 5 mg per mL, 15 mL
[11] Schedule 1, Part 1, omit entries for Carmellose in the form Eye drops containing carmellose sodium 10 mg per mL, 15 mL
[12] Schedule 1, Part 1, omit entries for Carmellose with glycerin
[13] Schedule 1, Part 1, omit entries for Cefepime
[14] Schedule 1, Part 1, after entry for Clonazepam in the form Tablet 2 mg [Maximum Quantity: 200; Number of Repeats: 2]
insert:
Clonazepam  Tablet 2 mg (S19A)  Oral  Clonazepam USP (Advagen Pharma, USA)  LM  MP NP  C11746  P11746  100  3     100
Clonazepam  Tablet 2 mg (S19A)  Oral  Clonazepam USP (Advagen Pharma, USA)  LM  MP NP  C6296   P6296   200  2     100

[15] Schedule 1, Part 1, omit entries for Colestyramine in the form Sachet containing 4 g oral powder (s19A)
[16] Schedule 1, Part 1, entries for Cyproterone in the form Tablet containing cyproterone acetate 100 mg
omit:
Cyproterone  Tablet containing cyproterone acetate 100 mg  Oral  Pharmacor Cyproterone 100  CR  MP             50   5     50
Cyproterone  Tablet containing cyproterone acetate 100 mg  Oral  Pharmacor Cyproterone 100  CR  MP     P14238  100  5     50

[17] Schedule 1, Part 1, entry for Dapagliflozin [Maximum Quantity: 28; Number of Repeats: 5]
(a) insert in numerical order in the column headed "Circumstances": C16220
(b) insert in numerical order in the column headed "Purposes": P16220
[18] Schedule 1, Part 1, entry for Dapagliflozin [Maximum Quantity: 56; Number of Repeats: 5]
(a) insert in numerical order in the column headed "Circumstances": C16164
(b) insert in numerical order in the column headed "Purposes": P16164
[19] Schedule 1, Part 1, entry for Dapagliflozin with metformin in the form Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride [Maximum Quantity: 56; Number of Repeats: 5]
(a) insert